Back to Archived Journals » Core Evidence » Volume 1-Issues 3 & 4 » Issue 4
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 1-Issues 3 & 4, 2006
Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
Louise Profit
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Ciclesonide in persistent asthma: the evidence of its therapeutic value
Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Aripiprazole: the evidence of its therapeutic impact in schizophrenia
William Winlow, Louise Profit, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Bortezomib: the evidence of its clinical impact in multiple myeloma
Simon Lancaster
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006